| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NuCana plc (NASDAQ: NCNA)
NCNA Technical Analysis
5
| As on 9th Jun 2023 NCNA STOCK Price closed @ 0.77 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.43 & Strong Sell for SHORT-TERM with Stoploss of 2.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NCNASTOCK Price
| Open | 0.77 | Change | Price | % |
| High | 0.77 | 1 Day | -0.01 | -1.28 |
| Low | 0.75 | 1 Week | -0.07 | -8.33 |
| Close | 0.77 | 1 Month | -0.08 | -9.41 |
| Volume | 30300 | 1 Year | -1.62 | -67.78 |
| 52 Week High 3.27 | 52 Week Low 0.59 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NCNA Daily Charts |
NCNA Intraday Charts |
Whats New @ Bazaartrend |
NCNA Free Analysis |
|
|
NCNA Important Levels Intraday
| RESISTANCE | 0.81 |
| RESISTANCE | 0.80 |
| RESISTANCE | 0.79 |
| RESISTANCE | 0.78 |
| SUPPORT | 0.76 |
| SUPPORT | 0.75 |
| SUPPORT | 0.74 |
| SUPPORT | 0.73 |
NCNA Forecast May 2024
| 4th UP Forecast | 2.62 |
| 3rd UP Forecast | 2.03 |
| 2nd UP Forecast | 1.66 |
| 1st UP Forecast | 1.29 |
| 1st DOWN Forecast | 0.25 |
| 2nd DOWN Forecast | -0.12 |
| 3rd DOWN Forecast | -0.49 |
| 4th DOWN Forecast | -1.08 |
NCNA Weekly Forecast
| 4th UP Forecast | 1.44 |
| 3rd UP Forecast | 1.23 |
| 2nd UP Forecast | 1.09 |
| 1st UP Forecast | 0.96 |
| 1st DOWN Forecast | 0.58 |
| 2nd DOWN Forecast | 0.45 |
| 3rd DOWN Forecast | 0.31 |
| 4th DOWN Forecast | 0.10 |
NCNA Forecast2024
| 4th UP Forecast | 6.15 |
| 3rd UP Forecast | 4.42 |
| 2nd UP Forecast | 3.36 |
| 1st UP Forecast | 2.29 |
| 1st DOWN Forecast | -0.75 |
| 2nd DOWN Forecast | -1.82 |
| 3rd DOWN Forecast | -2.88 |
| 4th DOWN Forecast | -4.61 |
NuCana plc ( NASDAQ USA Symbol : NCNA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NCNA Business Profile
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase III clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with metastatic pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors; and NUC-7738, a nucleoside analog that is in Phase I clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. NuCana plc has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom. Address: 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service